Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

astatine At 211 F(ab')2 MX35

A radioimmunoconjugate composed of the F(ab')2 fragment of monoclonal antibody MX35 targeting the sodium-dependent phosphate transport protein 2b (NaPi2b; SLC34A2) labeled with the alpha-emitting radionuclide astatine (At) 211 (211At), with potential antineoplastic activity. Upon administration of astatine At 211 F(ab')2 MX35, the F(ab')2 MX35 moiety targets and binds to NaPi2b-expressing tumor cells, thereby delivering a cytotoxic dose of alpha radiation directly to the NaPi2b-expressing tumor cells. NaPi2b, a multi-transmembrane, sodium-dependent phosphate transporter, is highly expressed in certain types of tumor cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:211 At astatine-labeled MX35 F(ab')2
211-astatine-MX35 F(ab')2
astatine At 211-MX35 F(ab')2
At211-MX35 F(ab')2
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search